Jia Lin

Dr. Jia Lin holds a Ph.D. in Oncology from Hebei Medical University and pursued a postdoctoral fellowship in Tumor Immunology at Harvard Medical School/ Massachusetts General Hospital. She has previously studied at Peking University Cancer Hospital and Sun Yat-sen University Affiliated Cancer Hospital, earning the title of “Outstanding Visiting Scholar of the 2016 Class, Peking University School of Medicine.”

Dr. Jia Lin is a renowned doctor in the field of Medical Oncology and has been working in this area for over 20 years. She has held positions at Hebei Cancer Hospital, Hebei University Affiliated Hospital, and a Guangzhou Tertiary Oncology Hospital. In terms of research, Dr. Jia Lin has participated in numerous national, provincial, and municipal projects, as well as two projects funded by the U.S. NIH RO1 program. She has published over 20 professional papers in domestic and international journals. Additionally, Dr. Jia Lin currently serves as a member of the Chinese Anti-Cancer Association (Committee of Tumor Microenvironment Youth Committee, Committee of Clinical Research on Tumor Drugs, Committee of Tumor Targeted Therapy), a member of the American Society of Clinical Oncology (ASCO), and a member of the American Association for Cancer Research (AACR).

Dr. Jia Lin specializes in the treatment of tumors such as breast, lung, urinary system, and gastrointestinal cancer. She also excels in palliative supportive therapy for advanced tumors and the management of complex and critical conditions related to cancer.